China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
RecruitingOBSERVATIONAL
Enrollment
100,000
Participants
Timeline
Start Date
August 31, 2021
Primary Completion Date
December 31, 2031
Study Completion Date
December 31, 2031
Conditions
Atopic Dermatitis EczemaPrurigo Nodularis
Trial Locations (1)
Unknown
RECRUITING
Peking University First Hospital, Beijing
All Listed Sponsors
lead
Peking University First Hospital
OTHER
NCT05316805 - China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project | Biotech Hunter | Biotech Hunter